AAG
DFTX icon

Armstrong Advisory Group’s Definium Therapeutics DFTX Stock Holding History

Armstrong Advisory Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.82K Buy
+153
New +$6.45K ﹤0.01% 785

Other funds holding DFTX

SCI
Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BWM
Bullock Wealth Management Bloomington, Indiana $241M AUM 23.31% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Armstrong Advisory Group's DFTX Position: Q3 2026 in Review

Armstrong Advisory Group opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 153 shares worth $5.82K. The stake represents ﹤0.01% of the portfolio and ranks #785 among its holdings.

8 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Armstrong Advisory Group held 153 shares of Definium Therapeutics worth $5.82K as of Q3 2026.
  • Definium Therapeutics was a new Armstrong Advisory Group position in Q3 2026.
  • Definium Therapeutics made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #785 holding.
  • 8 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.